STAT+: Kalshi comes for biopharma, with prediction markets for clinical trials and FDA approvals

Prediction markets have permeated the worlds of sports, politics, and reality television shows. Now, the biopharma industry could be next. On Thursday, Kalshi, one of the world’s largest prediction market exchanges, said it will start taking bets on clinical trials and regulatory approvals. It’s starting with a small number of markets chosen in collaboration with its partner, AppliedXL, a tech company that monitors and predicts the outcomes of clinical trials.Continue to STAT+ to read the full s...